Health Care & Life Sciences » Pharmaceuticals | Egalet Corp.

Egalet Corp.

Egalet Corp.
Stock Exchange NASDAQ Stock Market
EPS
 $0.91
Market Cap
 $21.58 M
Shares Outstanding
 56.77 M
Public Float
 43.77 M

Profile

Address
600 Lee Road
Wayne Pennsylvania 19087
United States
Employees -
Website http://www.egalet.com
Updated 09/14/2018
Egalet Corp. engages in the development, manufacture, and commercialization of innovative treatments for pain and other conditions. The firm offers ARYMO, OXAYDO and SPRIX. Its products contain non-narcotic and abuse-deterrent opioid formulations.

Financials

View All
Created with Highcharts 5.0.14Egalet Corp.Net Income. Fiscal year is January-December. All values USD Thousands.20 20720 20743 21443 21457 93357 93390 63290 63269 35969 35920132014201520162017025k50k75k100k
Created with Highcharts 5.0.14Egalet Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.001 9201 92022 83022 83016 96416 96426 13626 1362013201420152016201705k10k15k20k25k30k

Robert Samuel Radie
President, Chief Executive Officer & Director
John W. Varian
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.